Neuraminidase (NA) of influenza is a key target for antiviral inhibitors, and the 150-cavity in group-1 NA provides new insight in treating this disease. However, NA of 2009 pandemic influenza (09N1) was found lacking this cavity in a crystal structure. To address the issue of flexibility of the 150-loop, Hamiltonian replica exchange molecular dynamics simulations were performed on different groups of NAs. Free energy landscape calculated based on the volume of 150-cavity indicates that 09N1 prefers open forms of 150-loop. The turn A (residues 147–150) of the 150-loop is discovered as the most dynamical motif which induces the inter-conversion of this loop among different conformations. In the turn A, the backbone dynamic of residue 1...
The comparative dynamics and inhibitor binding free energies of group-1 and group-2 pathogenic influ...
One of the most conserved glycosylation sites of neuraminidase (NA) is 146-N-glycan. This site is ad...
<div><p>Influenza virus neuraminidase (iNA) is a homotetrameric surface protein of the influenza vir...
Neuraminidase (NA) of influenza is a key target for antiviral inhibitors, and the 150-cavity in grou...
Neuraminidase (NA) of influenza is a key target for antiviral inhibitors, and the 150-cavity in grou...
Plasticity of 150-loop in influenza neuraminidase explored by Hamiltonian replica exchange molecular...
Neuraminidase inhibitors are the main pharmaceutical agents employed for treatments of influenza inf...
Neuraminidase inhibitors are the main pharmaceutical agents employed for treatments of influenza inf...
Since the beginning of the last century, several pandemics with high morbidity and mortality caused ...
The recently discovered 150-cavity in the active site of group-1 influenza A neuraminidase (NA) prot...
It is critical to understand the molecular basis of the drug resistance of influenza viruses to effi...
<div><p>Quantitatively predicting changes in drug sensitivity associated with residue mutations is a...
It is critical to understand the molecular basis of the drug resistance of influenza viruses to effi...
The recently discovered 150-cavity in the active site of group-1 influenza A neuraminidase (NA) prot...
<div><p>One of the most conserved glycosylation sites of neuraminidase (NA) is 146-N-glycan. This si...
The comparative dynamics and inhibitor binding free energies of group-1 and group-2 pathogenic influ...
One of the most conserved glycosylation sites of neuraminidase (NA) is 146-N-glycan. This site is ad...
<div><p>Influenza virus neuraminidase (iNA) is a homotetrameric surface protein of the influenza vir...
Neuraminidase (NA) of influenza is a key target for antiviral inhibitors, and the 150-cavity in grou...
Neuraminidase (NA) of influenza is a key target for antiviral inhibitors, and the 150-cavity in grou...
Plasticity of 150-loop in influenza neuraminidase explored by Hamiltonian replica exchange molecular...
Neuraminidase inhibitors are the main pharmaceutical agents employed for treatments of influenza inf...
Neuraminidase inhibitors are the main pharmaceutical agents employed for treatments of influenza inf...
Since the beginning of the last century, several pandemics with high morbidity and mortality caused ...
The recently discovered 150-cavity in the active site of group-1 influenza A neuraminidase (NA) prot...
It is critical to understand the molecular basis of the drug resistance of influenza viruses to effi...
<div><p>Quantitatively predicting changes in drug sensitivity associated with residue mutations is a...
It is critical to understand the molecular basis of the drug resistance of influenza viruses to effi...
The recently discovered 150-cavity in the active site of group-1 influenza A neuraminidase (NA) prot...
<div><p>One of the most conserved glycosylation sites of neuraminidase (NA) is 146-N-glycan. This si...
The comparative dynamics and inhibitor binding free energies of group-1 and group-2 pathogenic influ...
One of the most conserved glycosylation sites of neuraminidase (NA) is 146-N-glycan. This site is ad...
<div><p>Influenza virus neuraminidase (iNA) is a homotetrameric surface protein of the influenza vir...